HomeAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$0.37
After Hours:(2.43%)-0.0090
$0.36
Closed: Jul 12, 6:06:02 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$0.36
Day range
$0.36 - $0.37
Year range
$0.31 - $0.75
Market cap
21.08M USD
Avg Volume
317.34K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 40.00K | -18.37% |
Operating expense | 5.77M | 32.73% |
Net income | -5.82M | -58.89% |
Net profit margin | -14.54K | -94.64% |
Earnings per share | -0.12 | -41.84% |
EBITDA | -5.68M | -33.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.94M | -64.53% |
Total assets | 16.19M | -56.79% |
Total liabilities | 11.36M | 359.48% |
Total equity | 4.83M | — |
Shares outstanding | 51.28M | — |
Price to book | 4.56 | — |
Return on assets | -80.60% | — |
Return on capital | -149.88% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -5.82M | -58.89% |
Cash from operations | -4.82M | -30.84% |
Cash from investing | -158.00K | -102.56% |
Cash from financing | 2.83M | 2,729.00% |
Net change in cash | -2.14M | 41.39% |
Free cash flow | -2.76M | -22.62% |
About
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Founded
1966
Headquarters
Website
Employees
27